Infection is the most devastating and expensive complication of joint arthroplasty [1, 2] . Antibiotic prophylaxis has demonstrated to be an effective preventive measure for this complication [3] . Because bacterial contamination occurs most frequently when the wound is open, the most important factor associated with the efficacy of antimicrobial prophylaxis is the presence of a high antibiotic concentration in tissues and blood bathing the wound during the whole period of the surgical procedure [4, 5] . It is possible to achieve this objective by infusing an antibiotic with a short half-life during the induction of anesthesia if the duration of the surgical procedure is !2 h. This is the case in the majority of orthopedic procedures, and it explains the well-documented efficacy of cefazolin or cefuroxime [6] .
When the surgical procedure is performed during ischemia (e.g., total knee arthroplasty), the antibiotic is administered before the tourniquet is inflated. Several authors [7, 8] measured the antibiotic concentration in bone and fat during total knee arthroplasty after administering the antibiotic at different intervals before inflating the tourniquet. The conclusion was that, by infusing the antibiotic 10 min before inflating the tourniquet, the concentration in bone and fat was over the MIC of cephalosporins for the main pathogens. However, 2 pilot studies that compared the outcome of knee arthroplasty performed with or without use of a tourniquet or with early release of a tourniquet observed a lower rate of infectious complications among patients in the arm that underwent surgical procedures without use of a tourniquet or with early release of it [9, 10] . A possible explanation is that the hematomas around knee prosthesis implanted during ischemia contain lower antibiotic concentrations than the hematomas around knee prosthesis implanted without ischemia. In the case of knee arthroplasty performed during ischemia, the blood reaches the wound after tourniquet release. This causes a delay of 60-80 min from the standard infusion of antibiotic (before tourniquet inflation). If an antibiotic with a half-life of 1.5 h (e.g., cefazolin or cefuroxime) is administered at the moment of tourniquet release, the blood bathing the wound will have a high antibiotic concentration. To evaluate the importance of a "tourniquet-release" dose, we developed a randomized and double-blind study of primary total knee arthroplasty performed during ischemia.
PATIENTS, MATERIALS, AND METHODS

Study design.
We performed a single-center, randomized, double-blind, placebo-controlled trial. Patients admitted to our hospital for a primary knee arthroplasty were randomized 1:1 to receive 1 of the 2 following prophylactic regimens: (1) placebo 10-30 min before inflation of the tourniquet and 1.5 g of cefuroxime 10 min before release of the tourniquet (experimental arm) or (2) 1.5 g of cefuroxime 10-30 min before inflation of the tourniquet and placebo 10 min before release of the tourniquet (standard arm). In both arms, a postoperative dose of 1.5 g of cefuroxime was administered at 6 h after the end of the surgical procedure (figure 1). Placebo was prepared using 100 mL of sodium chloride 0.9% serum (Baxter Laboratory) and vitamin complex (Cernevit; Baxter Laboratory) to obtain a color similar to that of cefuroxime. Both cefuroxime and placebo were prepared in the pharmacy service, and the final volume was 100 mL. The ethical committee of our hospital approved the protocol.
Patients. All of the patients (except those who were allergic to penicillin) who underwent a primary total knee arthroplasty and who signed the informed consent were included in the study. All of the operations were performed-after the patient received spinal anesthesia-in 4 operating rooms without laminar air-flow. To perform the knee arthroplasties, the Orthopedic Service created a knee unit with 7 expert surgeons. Seven additional general orthopedic surgeons collaborated to reach this goal. The leg was washed first with soap and then with 10% iodine povidone solution (Betadine, Meda Pharma Sau Laboratory). All of the prostheses were cemented; 1 profound and 1 superficial drain tube that were left after closing the wound were removed within the 48 h after the surgical procedure. No antimicrobial agent was added to the cement in any case. Indwelling urine catheters were used in all of the patients and were removed within the first 24 h after the surgical procedure. The patients were monitored daily during their hospital stay and at 15 days and 3, 6, and 12 months after being discharged from the hospital. The variables gathered were age, sex, comorbidity (diabetes mellitus, obesity, chronic obstructive pulmonary disease, liver cirrhosis, chronic renal failure, neoplasm, and solid organ transplantation), reason that indicated total knee arthroplasty, American Society of Anaesthesiologists score, the duration of the operation and ischemia, total volume obtained through drain tubes, duration of hospitalization, number of blood transfusions, deep-tissue infection rate (defined by Centers for Disease Control and Prevention criteria, [11] ) 3 and 12 months after the surgical procedure, and the microorganisms isolated from these infections. During the surgical procedure and the first 6 h after the procedure, an RBC transfusion was given when the hemoglobin level was !9 g/dL.
After this period, the threshold for RBC transfusion was !8 g/ dL; for patients with a history of cardiac ischemic disease, the transfusion threshold was 9 g/dL. The management of deep prosthetic joint infections included an open debridement and у3 deep cultures of synovial fluid samples (incubated in blood culture flasks) and periprosthetic tissue samples from different sites. Coagulase-negative staphylococci were considered to be pathogenic when at least 2 samples had positive culture results and had the same antibiogram. The remaining microorganisms were considered to be pathogenic when they were isolated from at least 1 sample.
Statistical analysis. The sample size was calculated on the basis of a previous deep-tissue infection rate (4%) in our institution when standard antibiotic prophylaxis was used. We postulated that the infection rate in the experimental arm might decrease to 1.5%. To demonstrate statistically significant differences between the groups, it was necessary to include 450 patients in each arm, assuming an error a of 5% and a statistical power of 80%. Continuous variables were compared using Student's t test, and categorical variables were compared using the x 2 test or Fisher's exact test, when necessary. A 2-tailed P value !.05 was considered to be statistically significant.
RESULTS
From September 2004 through December 2005, a total of 908 patients were randomized; 442 and 466 patients were allocated to the standard and experimental arms, respectively. The main characteristics of both groups are shown in table 1. There were no differences between the groups with regard to age, sex, comorbidity, type of surgeon (specialist or general orthopedic surgeon), American Society of Anaesthesiologists score, duration of the surgical procedure, number of blood transfusions, or fourth-day hematocrit. Twenty-eight deep-tissue infections (3.08% of patients) were identified after 12 months of followup. Twenty-four deep-tissue infections were diagnosed within the first 3 months of follow-up, and 4 were diagnosed at 4-12 months of follow-up. The etiology of the infections is shown in table 2. Twenty-seven microorganisms were isolated from patients with early infections; 17 were gram-positive cocci (63%), and 10 were aerobic gram-negative bacilli (37%). Of the gram-positive cocci, 15 were staphylococci; 5 (33.3%) of which were methicillin resistant (2 Staphylococcus aureus and 3 coagulase-negative staphylococci). Of the aerobic gram-negative bacilli, both Escherichia coli were extended-spectrum blactamase producers. The other gram-negative bacilli were multidrug-susceptible strains. Four microorganisms were isolated from 4 patients with late infections; 3 of these microorganisms were methicillin-resistant coagulase-negative staphylococci, and 1 was methicillin-susceptible S. aureus.
The deep-tissue infection rates in the standard and experimental groups were 3.4% and 1.9%, respectively, at 3 months of follow-up and 3.6% and 2.6%, respectively, at 12 months of follow-up. Although the infection rate was lower in the experimental arm (table 3), the difference was not statistically significant ( and , respectively). The character-P p .21 P p .44 istics of the patients who developed a deep-tissue infection after 12 months of follow-up are shown in table 4. Factors significantly associated with infection in the univariate analysis were having an American Society of Anaesthesiologists score of 3 or 4 and a low fourth-day hematocrit. The infection rates in the experimental and standard arms, whether the American Society of Anaesthesiologists score was 1 or 2 (2.5% vs 1.8%) or 3 or 4 (9.2% vs 7.7%), were not statistically significantly different.
DISCUSSION
There is abundant information demonstrating that the best moment to infuse prophylactic antibiotics is within 30-60 min before incision [4, 12] . However, none of the previous studies included surgical procedures performed during ischemia. To our knowledge, our study is the first randomized, placebocontrolled, double-blind study to analyze the most appropriate moment for prophylactic antibiotic administration during knee arthroplasty performed during ischemia. Previous clinical experiences have revealed that ischemia may impair the prophylactic efficacy of antibiotics administered before tourniquet inflation [9, 10] . A possible explanation for this fact could be the low serum antibiotic concentration reached at the end of the surgical procedure when the prophylaxis is administered in accordance with the standard regimen (figure 1). Zelenitsky et al. [13] demonstrated the critical effect of serum antibiotic concentration at closure on wound infection in the context of colorectal surgical procedures. At the end of the surgical procedures, especially those performed during ischemia, the process of hematoma formation starts and the contaminant microoganisms are entrapped in fibrin clots. During this process, it is essential to reach the highest serum antibiotic concentration to obtain high concentrations in the hematoma and pre- vent the growth of contaminant microorganisms during the subsequent 12-24 h. Richardson et al. [14] measured the concentration of cefamandole (a cephalosporin with a half-life of 0.8 h) in serum and drain fluid specimens obtained at the end of surgical procedures to determine the benefit of an intravenous dose of antibiotic at the time of tourniquet deflation in 32 knee replacement operations. The most important findings were that (1) the concentration of cefamandole in drain fluid specimens was directly proportional to the serum concentration at the time of tourniquet release and (2) the addition of a "tourniquet-release" dose of antibiotic increased concentration of antibiotic in drain fluid by 3-fold. The efficacy of a "tourniquet-release" dose (experimental arm) in our study was superior to efficacy of the standard administration; however, the difference was not statistically significant. The main drawback of the present study was that the difference in infection rate between the groups was lower than was initially predicted, and as a consequence, the number of patients necessary to find statistically significant differences would be higher. However, a decrease in the deep-tissue infection rate of 1% is of maximal importance, because ∼600,000 joint prostheses are implanted every year in the United States alone, and the estimated average cost of medical and surgical treatment of each prosthetic joint infection is US$30,000 [15] . The overall deep-tissue infection rate in our hospital was 3% (28 of 908 patients who underwent surgical procedures experienced an infection), which was higher than that reported by other authors [16] . The reasons for this discrepancy could be that (1) our study was prospectively controlled, (2) the operating room lacked a laminar air-flow system, and (3) the protocol of our hospital for the treatment of patients with suspected infection is very strict (when an infection was suspected, the patient underwent an open debridement). The reason for this protocol was based on the findings of Berbari et al. [17] that demonstrated that superficial infection was the main predictor for a prosthetic joint infection (OR, 35.9; 95% CI, 8.3-154.6), suggesting that superficial infections are often deeptissue infections. In fact, in our study, 24 of 28 deep-tissue infections (85.7%) were diagnosed within the 3 months after the surgical procedure was performed, and only 4 (14.3%) were diagnosed 4-12 months after the surgical procedure. In contrast, Peersman et al. [16] found that only one-third of deep-tissue infections occurred within the first 3 months, and the remaining two-thirds occurred after 3 months.
In conclusion, the administration of prophylactic antibiotics just before tourniquet release during knee arthroplasty performed during ischemia is not inferior to administration of standard antibiotic prophylaxis. In the future, it will be necessary to corroborate the usefulness of the "tourniquet-release" dose in a large clinical trial.
